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Abstract
Animal models are ideal to study the pathomechanism and therapy of acute pancreatitis
(AP). The use of L-arginine-induced AP model is nowadays becoming increasingly popular
in mice. However, carefully looking through the literature, marked differences in disease se-
verity could be observed. In fact, while setting up the L-arginine (2×4 g/kg i.p.)-induced AP
model in BALB/c mice, we found a relatively low rate (around 15%) of pancreatic necrosis,
whereas others have detected much higher rates (up to 55%). We suspected that this may
be due to differences between mouse strains. We administered various concentrations
(5–30%, pH = 7.4) and doses (2×4, 3×3, or 4×2.5 g/kg) of L-arginine-HCl in BALB/c, FVB/n
and C57BL/6 mice. The potential gender-specific effect of L-arginine was investigated in
C57BL/6 mice. The fate of mice in response to the i.p. injections of L arginine followed one
of three courses. Some mice (1) developed severe AP or (2) remained AP-free by 72 h,
whereas others (3) had to be euthanized (to avoid their death, which was caused by the
high dose of L-arginine and not AP) within 12 h., In FVB/n and C57BL/6 mice, the pancreatic
necrosis rate (about 50%) was significantly higher than that observed in BALB/c mice using
2×4 g/kg 10% L–arginine, but euthanasia was necessary in a large proportion of animals,
The i.p. injection of lower L-arginine concentrations (e.g. 5–8%) in case of the 2×4 g/kg
dose, or other L-arginine doses (3×3 or 4×2.5 g/kg, 10%) were better for inducing AP. We
could not detect any significant differences between the AP severity of male and female
mice. Taken together, when setting up the L-arginine-induced AP model, there are several
important factors that are worth consideration such as the dose and concentration of the ad-
ministered L arginine-HCl solution and also the strain of mice.
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Introduction
Acute pancreatitis (AP) is one of the most challenging diseases of the pancreas. The main
causes of AP are heavy alcohol consumption and gallstone disease [1]. The prevalence of both
etiological factors shows increasing tendency making the disease a widespread problem. Al-
though, 80% of cases are mild, the remaining 20% of the patients suffer from severe AP form.
The mortality of the latter group can reach 50%.
To study the pathomechanism and therapy of AP, usually animal models such as the
secretagouge-induced, the retrograde injection of bile acid-induced, the choline-deficient ethio-
nine-supplemented (CDE) diet-induced and the basic amino acid (L-arginine, L-ornithine or
L-lysine)-induced AP models are used [2][3]. None of these models is perfect; each has its own
advantages and disadvantages. The most commonly investigated AP model is induced by re-
petitive injections of secretagouges (like cholecystokinin or caerulein). This treatment causes
mild, edematous pancreatitis in rats and severe inflammation and cell damage in mice [which
require six to ten intraperitoneal (i.p.) injections given at hourly intervals]. [4] The retrograde
injection of bile acids produces patchy necrosis in the pancreatic head, but it involves the use of
general anesthesia and a surgical procedure. The CDE diet-induced AP model, which causes se-
vere necrotizing pancreatitis with hemorrhage, works only in young female mice, and this diet
is very expensive. The L-arginine-induced AP model was first described by Mizunuma et al. [5]
and Tani et al. [6] in rats. A single i.p. injection of 5 g/kg L-arginine selectively destroyed nearly
all of the pancreatic acinar cells [5]. It was not until 2007 that Dawra et al. [7] characterized the
L-arginine-induced model (2×4 g/kg i.p.) in BALB/c and C57BL/6 mice as well. This basic
amino acid-induced pancreatitis model is becoming increasingly popular as it is cheap, non-in-
vasive and easy to induce as it only requires two i.p. injections to produce severe necrotizing
disease [8][9][10]. However, carefully looking through the literature, marked differences in dis-
ease severity could be observed in mice. In fact, while setting up the L-arginine-induced AP
model in BALB/c mice, we found a relatively low rate (around 15%) of pancreatic necrosis in
response to the basic amino acid, whereas others have detected much higher rates (up to 55%)
in C57BL/6 mice [11][12][13].
Our overall aim was to characterize this increasingly popular AP model so that it can be
used with the greatest efficiency. Therefore, we decided to test the effects of L-arginine doses
and concentrations in different mouse strains. In addition, the gender dependence of this basic
amino acid-induced AP model was examined.
Materials and Methods
Ethics
All experiments were conducted in compliance with the Guide for the Care and Use of Labora-
tory Animals (National Academies Press, Eight Edition, 2011), and were approved by the Insti-
tutional Animal Care and Use Committee of the University of Szeged (I-74-3/2012 MÁB) and
also by an independent committee assembled by national authorities (XII./3773/2012.).
Animals and materials
Male and female mice weighing 20–25 g were used. FVB/n, C57BL/6 and BALB/c mouse
strains were from Charles Rivers Laboratory. The animals were kept at a constant room tem-
perature of 23°C with a 12 hour light–dark cycle and were allowed free access to water and
standard laboratory chow for rodents (Biofarm, Zagyvaszántó).
All chemicals were purchased from Sigma-Aldrich (Budapest, Hungary) unless
indicated otherwise.
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Induction of acute pancreatitis
L-arginine-HCl was dissolved in physiological saline (PS), and its pH was set to 7.4 with
NaOH. The L-arginine solution was prepared freshly before each experiment. Different con-
centrations (5, 8, 10 and 30%) and doses (2×4, 3×3 and 4×2.5 g/kg, administered at hourly in-
tervals) of L-arginine-HCl were administered i.p. Control animals were treated i.p. with PS
instead of L-arginine. Mice were sacrificed at the peak of pancreatic injury, 72 h after the first
i.p. injection following anesthesia with i.p. 85 mg/kg pentobarbital (Bimeda MTC, Cambridge,
Canada). Animals were exsanguinated through cardiac puncture, the pancreas was rapidly
removed and trimmed from fat and lymph nodes. Parts of the pancreatic tissue were immedi-
ately frozen in liquid nitrogen then stored at -80°C until biochemical assays were performed.
Another part of the pancreas was fixed in 6% neutral formaldehyde solution for histological
analysis. Blood samples were centrifuged at 2500 RCF for 15 min at 4°C and the serum was
stored at -20°C until use.
The mice became sluggish and lethargic soon after the i.p. L-arginine-HCl injections. Some
mice recovered within 12 h after the injections, but others remained unwell. Based on prelimi-
nary experiments and literature data, since the core temperature (measured rectally with a
digital thermometer, (TFC-305P, ONETEMP) of the latter mice decreased to critical levels
(27–29 °C) 12 h after the L-arginine injections, these animals were euthanized by pentobarbital
overdose (200 mg/kg i.p.) to minimize suffering [14][15]. The postmortem macroscopic and
histological analysis proved that these mice did not suffer from AP (data not shown). The sur-
viving mice gradually recovered from the L-arginine injections and either developed necrotiz-
ing AP or remained AP-free by 72 h (when the experiment was terminated). The effectivity
rate of AP induction is defined as (the number of mice which showed signs of AP divided
by the total number of mice injected with L-arginine) × 100. The signs of AP on histological
analysis included pancreatic edema, acinar cell damage, and inflammatory infiltration. The eu-
thanized animals and those that did not show any signs of AP according to the histological
analysis were excluded from the measurements (except in BALB/c mice treated with 2×4 g/kg
5% L-arginine-HCl which recovered from the L-arginine-HCl injections and none of the ani-
mals demonstrated signs of AP). Due to ethical issues, particularly in case of groups that need-
ed euthanasia in large proportions, the laboratory and histological analyses were performed on
a lower number of mice (in order to avoid the unnecessary death of animals).
Laboratory measurements
Serum amylase activity was measured with a colorimetric kinetic method using a commercial
kit purchased from Diagnosticum ZRt. (Budapest, Hungary).
To evaluate the water content of the pancreas, the pancreatic wet weight was measured,
then the tissue was dried for 24 h at 100°C and the dry weight was also measured. The dry
weight (DW) and wet weight (WW) ratio was calculated as: (1-DW/WW)100.
Pancreatic myeloperoxidase (MPO) activity is a hallmark of leukocytic infiltration and was
measured according to Kuebler et al. [16]. MPO activities were normalized to total protein con-
tent measured by the Lowry method [17].
To determine the extent of inflammatory response in the pancreata, we measured interleu-
kin (IL)-1β levels by a commercial ELISA kit from R&D Systems (Minneapolis, MN, USA) as
described previously [18].
Histological examination
Histological samples were prepared and stained with hematoxylin and eosin. Pancreatic sec-
tions were analysed and scored by a pathologist blinded to the experimental protocol. Edema
Strain- and Dose-Dependency of Pancreatitis
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was scored from 0–3 points (0: none; 1: patchy interlobular; 2: diffuse interlobular; 3: diffuse in-
terlobular and intraacinar), leukocytic infiltration from 0–3 points (0: none; 1: patchy interlob-
ular; 2: diffuse interlobular; 3: diffuse interlobular and intraacinar), the percentage of acinar
cell necrosis was evaluated by ImageJ software (NIH, Bethesda, MD, USA). Normal, non-AP
pancreatic samples from L-arginine-treated mice were eventually excluded from the
data analysis.
Statistical analysis
Data are presented as means ± SEM. Differences in euthanasia rates (mortality) were deter-
mined by chi square test with Yates correction. Laboratory and histological parameters were
evaluated by using the one–way analysis of variance (ANOVA) followed by Bonferroni post
hoc test, if the distribution of data was normal. Kruskal-Wallis non-parametric test with Dun-
nett’s multiple comparison post hoc test was used, if the distribution of data was not normal.
P<0.05 was accepted as statistically significant.
Results
The effects of L-arginine concentration on the development of acute
pancreatitis in BALB/c, C57BL/6 and FVB/n mice
In the original article by Dawra et al. [7], the 2×4 g/kg L-arginine-HCl dose was administered
as an 8% L-arginine solution. Since this involves the injection of a relatively large amount of
fluid, first we wanted to characterize the effects of various L-arginine concentrations (5%, 8%,
10% and 30%) on the development of AP in BALB/c mice. According to preliminary experi-
ments, the administration of 30% L-arginine solution (which is commonly used in rats for AP
induction) greatly increased the need of euthanasia (over 90% in all mouse strains), so we did
not proceed with this concentration any further. Interestingly, whereas treatment of mice with
2×4 g/kg 5% L-arginine solution did not cause any mortality or pancreatic damage (therefore,
its effectivity rate was 0) in the BALB/c strain, the effectivity rate of the 8 and 10% L-arginine-
treated groups was over 90% (Fig. 1A).
Fig. 1B-H and Table 1 show various laboratory and histological parameters that confirm the
development of experimental AP in the 8 and 10% L-arginine-treated groups, whereas no AP
was seen in the 0 and 5% treated groups. Notably, the extent of acinar cell damage was relative-
ly mild in pancreatitic animals. There were no significant differences in the measured parame-
ters of the 8 and 10% treated groups, so to decrease the volume load, we used a 10% L-arginine
solution for further studies.
Animals were treated as indicated in the legend of Fig. 1. The effects of L-arginine-HCl solu-
tion concentration on the induction of AP are shown in BALB/c mice based on measurements
of pancreatic water content, leukocytic infiltration score and necrosis rate. L-arginine-treated
mice that had no pancreatic inflammation on histology at the time of sacrifice were excluded
from the data analysis. : p<0.05 vs the control (0% L-arginine). Control group: n = 8, 5%
group: n = 12, 8% group: n = 11, 10% group: n = 11.
Next, we tested the effects of L-arginine concentration on the C57BL/6 mouse strain. Al-
though the effectivity rate of AP induction was 93% in the 5% L-arginine-treated group, it was
only 33% in the 10% L-arginine-treated group (Fig. 2A). The low effectivity rate in the latter
group was caused by the high euthanasia rate. Both laboratory and histological parameters con-
firmed the presence of AP in the groups treated with 5 and 10% L-arginine vs the physiological
saline-treated control group (Fig. 2B-H and Table 2). AP was more severe in the 10% vs 5% L-
arginine-treated group.
Strain- and Dose-Dependency of Pancreatitis
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Fig 1. The effect of L-arginine-HCl solution concentration on the induction of acute pancreatitis (AP)
in BALB/c mice. Animals were injected i.p. with different concentrations (5–10%) of L-arginine-HCl (pH =
7.4) at a dose of 2×4 g/kg (with an hourly interval) and were sacrificed 72 h after the first injection. The control
animals (0% L-arginine) were treated with physiological saline (PS). The number of total / sacrificed non-AP /
sacrificed APmice (based on histological analysis) were: 8 / 8 / 0 in the PS group, 12 / 12 / 0 in the 5% L-
arginine-treated group, 12 / 1 / 11 in the 8% L-arginine-treated group and 12 / 1 / 11 in the 10% L-arginine-
treated group. Animals that did not show any signs of AP according to histological analysis (sacrificed non-AP
mice) were excluded from the measurements (except in mice injected i.p. with 2×4 g/kg 5% L-arginine-HCl
solution, which did not demonstrate any signs of AP). A. The effectivity rate of AP induction is defined as (the
number of mice which showed signs of AP divided by the total number of mice injected with L-arginine) x 100.
B. Serum amylase activities, C. pancreatic myeloperoxidase (MPO) activities, andD. pancreatic interleukin
(IL)-1β levels were determined from the control group and animals with AP (except in the group treated with
Strain- and Dose-Dependency of Pancreatitis
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Animals were treated as indicated in the legend of Fig. 2. Pancreatic water content, leukocyt-
ic infiltration score and necrosis percentages were determined as indicated in the Methods.
Mice that were euthanized 12 h after the injections of L-arginine (not related to AP induction),
or L-arginine-treated mice that had no pancreatic inflammation on histology at the time of
sacrifice were excluded from the data analysis. p<0.05 vs the : control (0% L-arginine) or
the #: 5% L-arginine-treated group. Control group: n = 8, 5% group: n = 11, 10% group: n = 4.
Note that the low n number in the 10% L-arginine-treated group was due to ethical issues (to
avoid the unnecessary death of animals).
Similarly to that observed in C57BL/6 mice, in the FVB/n mouse strain the effectivity rate in
the 5% L-arginine-treated groups was 92%; however, it was only 25% in the 10% L-arginine-
treated group (Fig. 3A). Laboratory and histological parameters were significantly elevated in
the 5 and 10% L-arginine-treated groups, compared to the control group (Fig. 3B-H and
Table 3). However, there were no significant differences between the 5 and 10% L-arginine-
treated groups. Administration of 5 and 10% L-arginine caused similar degree of
pancreatic inflammation.
Animals were treated as indicated in the legend of Fig. 3. Pancreatic water content, leukocyt-
ic infiltration score and necrosis percentages were determined as indicated in the Methods.
Mice that were euthanized 12 h after the injections of L-arginine (not related to AP induction),
or L-arginine-treated mice that had no pancreatic inflammation on histology at the time of sac-
rifice were excluded from the data analysis. p<0.05 vs the : control (0% L-arginine) or the #: 5%
L-arginine-treated group. Control group: n = 8, 5% group: n = 11, 10% group: n = 3. Note that
the low n number in the 10% L-arginine-treated group was due to ethical issues (to avoid the un-
necessary death of animals).
Dose-response of L-arginine administration in C57BL/6 and FVB/n mice
BALB/c mice proved to be rather resistant against mortality and AP injury caused by i.p. injec-
tion of 2×4 g/kg L-arginine, whereas the other two mouse strains seemed to be much more sus-
ceptible. We figured that by using other L-arginine doses, we can reduce adverse effects and
increase pancreatic damage in C57BL/6 and FVB/n mice. Fig. 4 and Table 4 show the effectivity
rate and laboratory and histological parameters in response to i.p. injection of 2×4, 3×3, or
4×2.5 g/kg L-arginine (10%) in C57BL/6 mice. The 2×4 g/kg L-arginine dose resulted in a low
effectivity rate, because of the numerous euthanized mice. In contrast, the effectivity of AP in-
duction in response to administration of 3×3 g/kg or 4×2.5 g/kg L-arginine-HCl was signifi-
cantly higher vs the 2×4 g/kg L-arginine-HCl treated group (Fig. 4A). The severity of AP was
2×4 g/kg 5% L-arginine-HCl). The histological pictures show representative H&E staining of pancreatic
samples frommice treated i.p. with E. PS, F. 5% L-arginine,G. 8% L-arginine andH. 10% L-arginine. Scale
bar = 100 μm.*: p<0.05 vs the control group and 5% L-arginine-treated group.
doi:10.1371/journal.pone.0117588.g001
Table 1. The i.p. administration of 2×4 g/kg L-arginine-HCl (10%) induces acute pancreatitis with a
low degree of necrosis in BALB/c mice.
L-arginine cc. (%) (1-D.W./W.W.)*100 (%) Leukocytic infiltration (0–3) Necrosis (%)
0 69.0 ± 0.9 0 0
5 70.3 ± 0.4 0 0
8 76.2 ± 0.7 * 1.4 ± 0.2 * 13 ± 2 *
10 75.3 ± 0.8 * 1.5 ± 0.22 * 16 ± 2 *
doi:10.1371/journal.pone.0117588.t001
Strain- and Dose-Dependency of Pancreatitis
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not significantly different in the L-arginine-treated groups according to histological and labora-
tory parameters. Of note, the i.p. injection of 5×2 g/kg L-arginine-HCl at hourly intervals did
not cause any signs of AP (n = 5, data not shown). We found similar dose-response (2×4, 3×3,
or 4×2.5 g/kg L-arginine-HCl) results in FVB/n mice (data are not shown). There were no sig-
nificant differences between the effects of different L-arginine doses on the severity of AP.
Fig 2. The effect of L-arginine-HCl solution concentration on the induction of acute pancreatitis in C57BL/6 mice. Animals were treated with PS or
2×4 g/kg L-arginine-HCl i.p. as described in the legend of Fig. 1. The number of total / euthanized / sacrificed non-AP / sacrificed APmice (based on
histological analysis) were: 8 / 0 / 8 / 0 in the PS group, 12 / 0 / 1 / 11 in the 5% L-arginine-treated group, 12 / 7 / 1 / 4 in the 10% L-arginine-treated group.
The euthanized animals and those that did not show any signs of AP according to histological analysis (sacrificed non-APmice) were excluded from the
measurements. A. The effectivity rate of L-arginine-induced AP in C57BL/6 mouse strain.B. Serum amylase activities,C. pancreatic MPO activities, and
D. pancreatic IL-1β levels were determined from the control group and animals with AP. The histological pictures show representative H&E staining of
pancreatic samples frommice treated i.p. with E. PS, F. 5% L-arginine, andG. 10% L-arginine. Scale bar = 100 μm. p<0.05 vs the *: control group or the
#: 5% L-arginine-treated group.
doi:10.1371/journal.pone.0117588.g002
Strain- and Dose-Dependency of Pancreatitis
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Table 2. The i.p. administration of 2×4 g/kg L-arginine-HCl induces a more severe necrotizing acute
pancreatitis when a 10% vs 5% L-arginine solution is injected in C57BL/6 mice.
L-arginine cc. (%) (1-D.W./W.W.)*100 (%) Leukocytic infiltration (0–3) Necrosis (%)
0 68.8 ± 0.5 0 0
5 74.6 ± 0.7 * 1.0 ± 0.1 * 16 ± 2 *
10 84.8 ± 2.6 * # 2.8 ± 0.3 * # 54 ± 4 * #
doi:10.1371/journal.pone.0117588.t002
Fig 3. The effect of L-arginine-HCl solution concentration on the induction of acute pancreatitis in FVB/n mice. Animals were treated with PS or
2×4 g/kg L-arginine-HCl i.p. as described in the legend of Fig. 1. The number of total / euthanized / sacrificed non-AP / sacrificed APmice (based on
histological analysis) were: 8 / 0 / 8 / 0 in the PS group, 12 / 0 / 1 / 11 in the 5% L-arginine-treated group, 12 / 8 / 1 / 3 in the 10% L-arginine-treated group. The
euthanized animals and those that did not show any signs of AP according to histological analysis (sacrificed non-APmice) were excluded from the
measurements. A. The effectivity rate of L-arginine-induced AP in FVB/n mouse strain.B. Serum amylase activities,C. pancreatic MPO activities, and
D. pancreatic IL-1β levels were determined from the control group and animals with AP. The histological pictures show representative H&E staining of
pancreatic samples frommice treated i.p. with E. PS, F. 5% L-arginine, andG. 10% L-arginine. Scale bar = 100 μm. p<0.05 vs the *: control group or the
#: 5% L-arginine-treated group.
doi:10.1371/journal.pone.0117588.g003
Strain- and Dose-Dependency of Pancreatitis
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Table 3. The i.p. administration of 2×4 g/kg L-arginine-HCl (10%) induces a similar degree of severe
necrotizing acute pancreatitis in FVB/n mice treated with 5% or 10% L-arginine-HCl solution.
L-arginine cc. (%) (1-D.W./W.W.)*100 (%) Leukocytic infiltration (0–3) Necrosis (%)
0 69.3 ± 0.6 0 0
5 77.7 ± 0.8 * 2.0 ± 0.2 * 43 ± 7 *
10 84.2 ± 0.4 * # 2.3 ± 0.3 * 48 ± 6 *
doi:10.1371/journal.pone.0117588.t003
Fig 4. The dose-response of L-arginine-HCl administration in C57BL/6 mice.Mice were treated with PS
or different i.p. doses (2×4, 3×3 and 4×2.5 g/kg given at 1-h intervals) of L-arginine-HCl (10%, pH = 7.4) and
Strain- and Dose-Dependency of Pancreatitis
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Mice were treated as indicated in the legend of Fig. 4. Pancreatic water content, leukocytic
infiltration score and necrosis percentages were determined as indicated in the Methods. Mice
that were euthanized 12 h after the injections with L-arginine, or L-arginine-treated mice that
had no pancreatic inflammation on histology at the time of sacrifice were excluded from the
data analysis. : p<0.05 vs the control (0 g/kg L-arginine). Control group: n = 10, 2×4 g/kg L-
arginine-treated group: n = 5, 3×3 g/kg L-arginine-treated group: n = 12, 4×2.5 g/kg L-arginine-
treated group: n = 12.
The severity of L-arginine-induced acute pancreatitis is similar in male
and female mice
As some AP models show gender dependency (e.g. female mice are more susceptible to CDE
diet-induced AP), we wanted to test the effects of L-arginine administration in male and female
mice. C57BL/6 mice were subjected to hourly i.p. injections of 3×3 g/kg 10% L-arginine-HCl.
The effectivity rate of AP induction was 87.5% in male (n = 8) and 100% in female (n = 8)
mice, which was not significantly different. The laboratory and histological parameters were
similar to that shown in Fig. 2B-G.
Discussion
An important finding of our experiments is it that different mouse strains have varying sensi-
tivities (resulting in AP, no pancreatic damage, or death) to administration of L-arginine-HCl
(pH = 7.4) (Table 5.). In FVB/n and C57BL/6 mice, which are commonly used strains for gen-
erating transgenic animals, the originally published i.p. 2×4 g/kg L-arginine-HCl dose may not
be appropriate and the use of other doses (like 3×3 g/kg or 4×2.5 g/kg) may be better for the in-
duction of AP. Furthermore, the concentration of the administered L-arginine-HCl solution
makes a huge difference in whether the animals survive the treatment. High L-arginine concen-
trations like 30%, which are well tolerated by rats actually kill mice, thus lower (5–10%) con-
centrations should be injected even if this means considerably more fluid volume.
Interestingly, we could not detect any differences in AP severity of male and female mice.
were sacrificed 72 h after the first injection. The number of all total / euthanized / sacrificed non-AP / sacrificed
APmice (based on histological analysis) were: 10 / 0 / 10 / 0 in the PS group, 14 / 8 / 1 / 5 in the 2×4 g/kg L-
arginine-treated group, 14 / 1 / 1 / 12 in the 3×3 g/kg L-arginine-treated group, 14 / 0 / 2 / 12 in the 4×2.5 g/kg
L-arginine-treated group. The euthanized animals and those that did not show any signs of AP according to
histological analysis (sacrificed non-APmice) were excluded from the measurements. A. The effectivity rate
of L-arginine-induced AP C57BL/6 mouse strain.B. Serum amylase activities,C. pancreatic MPO activities,
andD. pancreatic IL-1β levels were determined from the control group and animals with AP. Representative
H&E staining of pancreatic samples frommice treated i.p. with E. PS, F. 2×4 g/kg L-arginine-HCl,G. 3×3 g/kg
L-arginine-HCl andH. 4×2.5 g/kg L-arginine-HCl. Scale bar = 100 μm. p<0.05 vs the *: control group or the
#: 2×4 g/kg L-arginine-treated group. Note that significance was borderline (p = 0.053) in case of PS- vs
2×4 g/kg L-arginine-treated groups.
doi:10.1371/journal.pone.0117588.g004
Table 4. Acute pancreatitis severity in response to the i.p administration of 2×4, 3×3 or 4×2.5 g/kg L-
arginine-HCl (10%) is similar in C57BL/6 mice.
L-arginine dose (g/kg) (1-D.W./W.W.)*100 (%) Leukocytic infiltration (0–3) Necrosis (%)
0 67.7 ± 1.1 0 0
2x4 82.8 ± 2.2 * 2.6 ± 0.3 * 60 ± 12 *
3x3 81.4 ± 0.9 * 2.3 ± 0.2 * 52 ± 6 *
4x2.5 80.8 ± 0.8 * 2.3 ± 0.2 * 50 ± 5 *
doi:10.1371/journal.pone.0117588.t004
Strain- and Dose-Dependency of Pancreatitis
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Considering the adverse effects of large L-arginine doses (that would have lead to the death
of animals without euthanasia), the sensitivity of FVB/n and C57BL/6 strains to the basic
amino acid was much higher than that of BALB/c mice. In fact, it seems that the most L-argi-
nine resistant mouse strain is the BALB/c. In this strain, we found no mortality in response to
i.p. injection of 2×4 g/kg L-arginine-HCl. In accord with our observations, Dawra et al. [7]
(who have also used BALB/c mice) reported no mortality in their original study. In contrast,
we had to utilize euthanasia in a large proportion of FVB/n and C57BL/6 mice after the i.p. ad-
ministration of 2×4 g/kg L-arginine-HCl. The cause of death is unrelated to AP and may be
due to metabolic [like severe metabolic acidosis detected in rats by Bohus et al. [19]] or central
nervous system effects. The reasons for the above mentioned discrepancies are not clear, but
the dose response of rats to i.p. administration of L-arginine [19] and L-lysine [20] can be vari-
able even in one animal strain, although no such effects have been reported in mice. Sprague-
Dawley rats treated with a high dose (4 g/kg) of i.p. L-arginine caused weak, normal and strong
response [19]. Weak responders had no marked alterations vs the saline-treated control group,
whereas strong responders died. In our hands, the administration of 3.5 g/kg L-arginine causes
marked pancreatic inflammation and cell damage, but no mortality [18]; however, we have
also observed a small percentage of mortality with the 4 g/kg L-arginine-HCl dose in male Wis-
tar rats (unpublished data). Similarly to the data of Bohus et al.[19], the i.p. injection of large
L-lysine doses caused nil to severe pancreatic damage or death of rats [20]. Based on the above
mentioned data, we speculate that there may be differences in basic amino acid sensitivities
even within the same mouse strain.
Most commonly, an i.p. dose of 2×4 g/kg L-arginine-HCl is used for the induction of AP,
which was initially used in the current study as well. The utilization of higher [21][22], and
some rather odd [23][24][25][26][27] L-arginine doses have also been reported. Previously
published L-arginine doses ranging from 1×0.000004 g/kg [25] to 2×2.25 g/kg [27] adminis-
tered in mice do not cause any signs of AP in our hands (data not shown). Similarly, Dawra
et al. [7] could not detect any significant changes in serum amylase activity, and pancreatic
MPO activity and histopathology in response to i.p. 2×2 g/kg or 2×3 g/kg L-arginine-HCl in
BALB/c mice. However, we have clearly shown that the administration of 3×3 g/kg or 4×2.5 g/kg
L-arginine-HCl induced severe AP in the majority of FVB/n and C57BL/6 mice, but caused a
marked reduction of adverse effects (resulting in euthanasia) vs the 2×4 g/kg dose. When we
administered the same L-arginine doses in the three mouse strains, AP severity was nearly the
same in FVB/n and C57BL/6 mice, but it was markedly less in BALB/c mice. The strain-depen-
dent susceptibility to cerulein- and CDE diet-induced AP was reported by Wang et al. [4]. The
severity of experimental pancreatitis in their study was moderate in BALB/c and mild in
C57BL/6J mice. This difference in susceptibility was attributed to a positive relationship with
proteinase, serine, 1 (PRSS1) expression and a negative relationship with serine protease
Table 5. Summary of the effectivity rates and the severity of acute pancreatitis in different mouse strains.
Strain FVB/n C57Bl/6 Balb/c
Dose (g/kg) 2×4 2×4 3×3 or 4×2.5 2×4 2×4 3×3 or 4 ×2.5 2×4 2×4 3×3 or 4 ×2.5
Cc (%) 5 10 10 5 10 10 5 8 or 10 10
Effectivity rate +++ + ++ +++ + + 0 +++ ++
Severity of AP +++ +++ ++ + +++ +++ 0 + +
Mouse strains, L-arginine doses and concentrations are shown.
Bold = not suggested, Italics = data not shown in the article.
doi:10.1371/journal.pone.0117588.t005
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inhibitor, Kazal type 3 (SPINK3) expression. In L-arginine-induced AP, this may not be the
case since disease severity was significantly higher in C57BL/6 vs BALB/c mice.
The effects of the estrous cycle on AP development have always been a concern of research-
ers, thus to exclude such potential effects, usually male animals are used. In fact, it has long
been known that in case of the CDE diet model, the effects are gender specific, female mice are
much more sensitive to treatment [28]. Therefore, we also tested the potential gender-specific
effects of L-arginine treatment, but we found no significant differences in AP severity of male
vs female C57BL/6 mice.
Taken together, it is evident that setting up the L-arginine-induced AP model in mice is
quite challenging. Overall, it seems that the borderline between the effective (AP inducing) and
lethal doses of L-arginine is much thinner in mice vs rats. There are several important factors
that need to be considered such as the concentration and dose of the injected L-arginine-HCl
solution and also the strain of mice. The proper dosing of L-arginine to induce AP should be
tested by each laboratory and in each mouse strain. The reasons for the differences in L-argi-
nine sensitivity of mice remain to be investigated.
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